AstraZeneca Sues HHS over Drug Pricing Program Advisory Opinion Regarding Contract Pharmacies
By EsqSocial Corporation 02/02/21
On January 12, 2021, AstraZeneca Pharmaceuticals LP filed a complaint in Delaware federal court against the Department of Health and Human Services (HHS) for issuing an invalid Advisory Opinion. The 340B Drug Pricing Program, 42 U.S.C. ยง 256b (Section 340B) ......
By: Cozen O'Connor